ASUS simply scored a serious win on the earth of digital well being as a result of its VivoWatch ECG app has formally been licensed by Thailand’s FDA.
Based on ASUS COO and World SVP Joe Hsieh, this certification not solely confirms the accuracy of their ECG expertise but additionally alerts the corporate’s rising push to ship high-quality, accessible well being monitoring options on a world scale.
For those who’re utilizing the ASUS VivoWatch 6 or VivoWatch 6 AERO, the ECG app permits you to take a 30-second coronary heart studying simply by touching the watch face together with your fingertip. As soon as achieved, you get prompt outcomes and the choice to share them instantly together with your physician—no additional devices or sophisticated steps required.
However this isn’t nearly on a regular basis customers, ASUS says the tech is absolutely prepared to be used in hospitals, clinics, and even VIP-focused healthcare setups. On prime of the brand new ECG operate, the VivoWatch additionally tracks blood strain, which means customers can preserve tabs on two main cardiovascular markers in a single gadget—good for proactive monitoring and early detection.
For those who’ve received a supported VivoWatch, all it takes to unlock the ECG function is a fast replace to each your watch software program and the ASUS HealthConnect app.
Elevate your perspective with NextTech Information, the place innovation meets perception.
Uncover the newest breakthroughs, get unique updates, and join with a world community of future-focused thinkers.
Unlock tomorrow’s developments as we speak: learn extra, subscribe to our publication, and grow to be a part of the NextTech group at NextTech-news.com
